A Randomized Phase II Trial of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Surgical Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF-1)

Grant

Date/time Interval

  • January 1, 2015 - January 1, 2019
  • Total Award Amount

  • 200002.00
  • Direct Costs

  • 181820.00
  • Sponsor Award Id

  • G140004/A002
  • Contributor

  • Korf M.D., Ph.D., Bruce   Principal Investigator